{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:29:51Z","timestamp":1787624991162,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070133"],"award-info":[{"award-number":["82070133"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.bcmd.2024.102855","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T01:06:48Z","timestamp":1714180008000},"page":"102855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Decreasing circ_0014614 promotes the differentiation of bone marrow flineage cells into megakaryocytes in essential thrombocythemia via activiation of miR-138-5p\/caspase3 axis"],"prefix":"10.1016","volume":"107","author":[{"given":"Guopan","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changxin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9477-9286","authenticated-orcid":false,"given":"Dan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcmd.2024.102855_bb0005","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1556\/2060.2023.00261","article-title":"BCR::ABL1 negative myeloproliferative neoplasms: a review focused on essential thrombocythemia and polycythemia vera","volume":"110","author":"Khodier","year":"2023","journal-title":"Physiol. Int."},{"key":"10.1016\/j.bcmd.2024.102855_bb0010","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/MOH.0b013e3283497f54","article-title":"The pathogenesis of essential thrombocythemia","volume":"18","author":"Beer","year":"2011","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.bcmd.2024.102855_bb0015","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcmd.2024.102855_bb0020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood-2015-07-661983","article-title":"Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients","volume":"127","author":"Cabagnols","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2024.102855_bb0025","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/ejh.12614","article-title":"Long-term follow-up of essential thrombocythemia patients treated with anagrelide: subgroup analysis according to JAK2\/CALR\/MPL mutational status","volume":"96","author":"Mela Osorio","year":"2016","journal-title":"Eur. J. Hematol."},{"key":"10.1016\/j.bcmd.2024.102855_bb0030","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s12253-014-9885-4","article-title":"JAK2 V617F, MPL, and CALR mutations in essential thrombocythaemia and major thrombotic complications: a single-institute retrospective analysis","volume":"21","author":"P\u00f3sfai","year":"2015","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.bcmd.2024.102855_bb0035","doi-asserted-by":"crossref","first-page":"11215","DOI":"10.1038\/ncomms11215","article-title":"Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs","volume":"7","author":"Zheng","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcmd.2024.102855_bb0040","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/15476286.2015.1020271","article-title":"Regulation of circRNA biogenesis","volume":"12","author":"Chen","year":"2015","journal-title":"RNA Biol."},{"key":"10.1016\/j.bcmd.2024.102855_bb0045","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature11928","article-title":"Circular RNAs are a large class of animal RNAs with regulatory potency","volume":"495","author":"Memczak","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2024.102855_bb0050","first-page":"984","article-title":"Comprehensive characterization of tissue-specific circular RNAs in the human and mouse genomes","volume":"18","author":"Xia","year":"2017","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.bcmd.2024.102855_bb0055","first-page":"23","article-title":"CircRNAs as potential blood biomarkers and key elements in regulatory networks in gastric cancer","author":"Reis-das-Merc\u00eas","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcmd.2024.102855_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.786224","article-title":"Exosomal circRNAs: emerging players in tumor metastasis","volume":"9","author":"Zhou","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcmd.2024.102855_bb0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41419-020-2230-9","article-title":"circRNA-002178 act as a ceRNA to promote PDL1\/PD1 expression in lung adenocarcinoma","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcmd.2024.102855_bb0070","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/s41388-019-1030-0","article-title":"NUDT21 regulates circRNA cyclization and ceRNA crosstalk in hepatocellular carcinoma","volume":"39","author":"Li","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.bcmd.2024.102855_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.81","article-title":"CircRNAs in hematopoiesis and hematological malignancies","volume":"6","author":"Bonizzato","year":"2016","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.bcmd.2024.102855_bb0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fnmol.2016.00025","article-title":"Roles of circular RNAs in neurologic disease","volume":"9","author":"Shao","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bcmd.2024.102855_bb0085","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s00018-019-03345-5","article-title":"CircRNA: a rising star in gastric cancer","volume":"77","author":"Li","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcmd.2024.102855_bb0090","first-page":"18","article-title":"Characterization of hsa_circ_0004277 as a new biomarker for acute myeloid leukemia via circular RNA profile and bioinformatics analysis","author":"Li","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcmd.2024.102855_bb0095","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/cbin.11534","article-title":"Differential expression of circular RNAs in bone marrow-derived exosomes from essential thrombocythemia patients","volume":"45","author":"Wang","year":"2021","journal-title":"Cell Biol. Int."},{"issue":"11\u221212","key":"10.1016\/j.bcmd.2024.102855_bb0100","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1007\/s00018-009-8775-5","article-title":"Regulation of megakaryocytic differentiation of K562 cells by FosB, a member of the Fos family of AP-1 transcription factors","volume":"66","author":"Limb","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcmd.2024.102855_bb0105","first-page":"668","article-title":"MicroRNA-138 regulates cell adhesion-mediated drug resistance phenotype by targeting SGTA in non-Hodgkin\u2019s lymphoma","volume":"39","author":"Wu","year":"2018","journal-title":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi"},{"key":"10.1016\/j.bcmd.2024.102855_bb0115","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/onc.2012.557","article-title":"BCR-ABL\/GATA1\/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia","volume":"33","author":"Xu","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.bcmd.2024.102855_bb0120","article-title":"Dysregulation of miR-138-5p\/RPS6KA1-AP2M1 is associated with poor prognosis in AML","volume":"9","author":"Yu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcmd.2024.102855_bb0125","first-page":"272","article-title":"Effect of miR-138-5p targeting HIF-1\u03b1 on proliferation and invasion and metastasis of human leukemia K562 cells","volume":"29","author":"Guo","year":"2020","journal-title":"J. Reg. Anatom. Operat. Surg."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979624000330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979624000330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T18:53:30Z","timestamp":1717354410000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979624000330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":24,"alternative-id":["S1079979624000330"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2024.102855","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreasing circ_0014614 promotes the differentiation of bone marrow flineage cells into megakaryocytes in essential thrombocythemia via activiation of miR-138-5p\/caspase3 axis","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2024.102855","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102855"}}